Clinical efficacy and safety of TACE combined with lenvatinib and PD-1 antibody in treatment of intermediate-advanced hepatocellular carcinoma

Clinical efficacy and safety of TACE combined with lenvatinib and PD-1 antibody in treatment of intermediate-advanced hepatocellular carcinoma

Objective To analyze the clinical efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with lenvatinib and PD-1 antibody in the treatment of intermediate-advanced hepatocellular carcinoma (HCC). Methods A retrospective cohort trial was conducted on 105 patients with interm...

Full description

Saved in:
Bibliographic Details
Main Authors: JIANG Jiayun, ZHANG Hui, ZHANG Shiyu
Format: Article
Language:zho
Published: Editorial Office of Journal of Army Medical University 2024-11-01
Series:陆军军医大学学报
Subjects:
hepatocellular carcinoma
lenvatinib
immunotherapy
pd-1 antibody
Online Access:https://aammt.tmmu.edu.cn/html/202405116.htm
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items